Literature DB >> 22796646

Complex I and ATP synthase mediate membrane depolarization and matrix acidification by isoflurane in mitochondria.

Danijel Pravdic1, Naoyuki Hirata, Lauren Barber, Filip Sedlic, Zeljko J Bosnjak, Martin Bienengraeber.   

Abstract

Short application of the volatile anesthetic isoflurane at reperfusion after ischemia exerts strong protection of the heart against injury. Mild depolarization and acidification of the mitochondrial matrix are involved in the protective mechanisms of isoflurane, but the molecular basis for these changes is not clear. In this study, mitochondrial respiration, membrane potential, matrix pH, matrix swelling, ATP synthesis and -hydrolysis, and H(2)O(2) release were assessed in isolated mitochondria. We hypothesized that isoflurane induces mitochondrial depolarization and matrix acidification through direct action on both complex I and ATP synthase. With complex I-linked substrates, isoflurane (0.5mM) inhibited mitochondrial respiration by 28 ± 10%, and slightly, but significantly depolarized membrane potential and decreased matrix pH. With complex II- and complex IV-linked substrates, respiration was not changed, but isoflurane still decreased matrix pH and depolarized mitochondrial membrane potential. Depolarization and matrix acidification were attenuated by inhibition of ATP synthase with oligomycin, but not by inhibition of mitochondrial ATP- and Ca(2+)-sensitive K(+) channels or uncoupling proteins. Isoflurane did not induce matrix swelling and did not affect ATP synthesis and hydrolysis, but decreased H(2)O(2) release in the presence of succinate in an oligomycin- and matrix pH-sensitive manner. Isoflurane modulated H(+) flux through ATP synthase in an oligomycin-sensitive manner. Our results indicate that isoflurane-induced mitochondrial depolarization and acidification occur due to inhibition of the electron transport chain at the site of complex I and increased proton flux through ATP synthase. K(+) channels and uncoupling proteins appear not to be involved in the direct effects of isoflurane on mitochondria.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796646      PMCID: PMC3653412          DOI: 10.1016/j.ejphar.2012.07.003

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  41 in total

1.  Monitoring mitochondrial electron fluxes using NAD(P)H-flavoprotein fluorometry reveals complex action of isoflurane on cardiomyocytes.

Authors:  Filip Sedlic; Danijel Pravdic; Naoyuki Hirata; Yasushi Mio; Ana Sepac; Amadou K Camara; Tetsuro Wakatsuki; Zeljko J Bosnjak; Martin Bienengraeber
Journal:  Biochim Biophys Acta       Date:  2010-07-17

2.  Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria.

Authors:  Peter J Hanley; John Ray; Ulrich Brandt; Jürgen Daut
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

3.  Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport.

Authors:  Mirian M da Silva; Adriano Sartori; Eduardo Belisle; Alicia J Kowaltowski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-03-06       Impact factor: 4.733

4.  Uncoupling of oxidative phosphorylation in rat liver mitochondria by general anesthetics.

Authors:  H Rottenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation.

Authors:  Cevher Ozcan; Martin Bienengraeber; Petras P Dzeja; Andre Terzic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

6.  Production of reactive oxygen species by mitochondria: central role of complex III.

Authors:  Qun Chen; Edwin J Vazquez; Shadi Moghaddas; Charles L Hoppel; Edward J Lesnefsky
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

7.  Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane.

Authors:  Adrian J Lambert; Martin D Brand
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

Review 8.  Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics.

Authors:  David F Stowe; Leo G Kevin
Journal:  Antioxid Redox Signal       Date:  2004-04       Impact factor: 8.401

9.  Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts.

Authors:  Leo G Kevin; Enis Novalija; Matthias L Riess; Amadou K S Camara; Samhita S Rhodes; David F Stowe
Journal:  Anesth Analg       Date:  2003-04       Impact factor: 5.108

10.  K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart.

Authors:  Peter J Hanley; Markus Mickel; Monika Löffler; Ulrich Brandt; Jürgen Daut
Journal:  J Physiol       Date:  2002-08-01       Impact factor: 5.182

View more
  14 in total

1.  Isoflurane modulates cardiac mitochondrial bioenergetics by selectively attenuating respiratory complexes.

Authors:  Bhawana Agarwal; Ranjan K Dash; David F Stowe; Zeljko J Bosnjak; Amadou K S Camara
Journal:  Biochim Biophys Acta       Date:  2013-12-17

Review 2.  Anaesthetics as cardioprotectants: translatability and mechanism.

Authors:  C Kikuchi; S Dosenovic; M Bienengraeber
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

3.  Anaesthetic Postconditioning at the Initiation of CPR Improves Myocardial and Mitochondrial Function in a Pig Model of Prolonged Untreated Ventricular Fibrillation.

Authors:  Matthias L Riess; Timothy R Matsuura; Jason A Bartos; Martin Bienengraeber; Mohammed Aldakkak; Scott H McKnite; Jennifer N Rees; Tom P Aufderheide; Mohammad Sarraf; Robert W Neumar; Demetris Yannopoulos
Journal:  Resuscitation       Date:  2014-10-02       Impact factor: 5.262

4.  Quantitative characterization of changes in the cardiac mitochondrial proteome during anesthetic preconditioning and ischemia.

Authors:  Martin Bienengraeber; Molly Pellitteri-Hahn; Naoyuki Hirata; Tesfaye M Baye; Zeljko J Bosnjak; Michael Olivier
Journal:  Physiol Genomics       Date:  2013-01-08       Impact factor: 3.107

5.  Isoflurane and low-level carbon monoxide exposures increase expression of pro-survival miRNA in neonatal mouse heart.

Authors:  Samantha M Logan; Aakriti Gupta; Aili Wang; Richard J Levy; Kenneth B Storey
Journal:  Cell Stress Chaperones       Date:  2021-03-04       Impact factor: 3.667

6.  Isoflurane reduces hypoxia/reoxygenation-induced apoptosis and mitochondrial permeability transition in rat primary cultured cardiocytes.

Authors:  Wanjun Wu; Xianju Zhou; Ping Liu; Weidong Fei; Li Li; Huifang Yun
Journal:  BMC Anesthesiol       Date:  2014-03-10       Impact factor: 2.217

Review 7.  Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injury.

Authors:  Bhawana Agarwal; David F Stowe; Ranjan K Dash; Zeljko J Bosnjak; Amadou K S Camara
Journal:  Front Physiol       Date:  2014-09-16       Impact factor: 4.566

Review 8.  Cardioprotection with halogenated gases: how does it occur?

Authors:  Jose Luis Guerrero-Orriach; Juan Jose Escalona Belmonte; Alicia Ramirez Fernandez; Marta Ramirez Aliaga; Manuel Rubio Navarro; Jose Cruz Mañas
Journal:  Drug Des Devel Ther       Date:  2017-03-16       Impact factor: 4.162

Review 9.  Chemical Conditioning as an Approach to Ischemic Stroke Tolerance: Mitochondria as the Target.

Authors:  Zhen Jin; Jinzi Wu; Liang-Jun Yan
Journal:  Int J Mol Sci       Date:  2016-03-08       Impact factor: 5.923

10.  Quantitative Proteomic Profiling of Mitochondrial Toxicants in a Human Cardiomyocyte Cell Line.

Authors:  Zhengxi Wei; Jinghua Zhao; Jake Niebler; Jian-Jiang Hao; B Alex Merrick; Menghang Xia
Journal:  Front Genet       Date:  2020-07-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.